sr 46349b has been researched along with Muscle Contraction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Callas, D; Fareed, J; Herbert, JM; Yang, LH | 1 |
| Breliere, JC; Congy, C; Gautret, B; Labeeuw, B; Le Fur, G; Neliat, G; Rinaldi-Carmona, M; Santucci, V; Simiand, J; Soubrie, P | 1 |
2 other study(ies) available for sr 46349b and Muscle Contraction
| Article | Year |
|---|---|
Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349).
Topics: Animals; Dose-Response Relationship, Drug; Fluorobenzenes; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Phenols; Platelet Aggregation; Rabbits; Rats; Rats, Sprague-Dawley; Serotonin Antagonists | 1996 |
Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.
Topics: Animals; Brain; Electroencephalography; Escape Reaction; Female; Fluorobenzenes; Guinea Pigs; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Phenols; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists; Sleep | 1992 |